Who Paid My Doc Search
Menu
Product Program year 2019 Source: CMS Open Payments

Rebinyn

Drug Hemophilia

NDC 0169-7905-01

Open in the dashboard

General payments

$166,965

348 payments

Research payments

$553,302

402 payments

Through program year 2019, $166,965 in general payments and $553,302 in research payments were reported against Rebinyn (Hemophilia).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $166,965 348
2019 Research $553,302 402

Breakdown

Who paid General payments · program year 2019
  1. Novo Nordisk AS $107,645 40 payments
  2. Novo Nordisk Inc $59,320 308 payments
Top recipients General payments · program year 2019
  1. Claudio Sandoval Pediatric Hematology-Oncology · Hawthorne, NY $19,219 12% · 11 payments
  2. Shveta Gupta Pediatric Hematology-Oncology · Orlando, FL $15,251 9% · 11 payments
  3. Hassan Yaish Pediatric Hematology-Oncology · Salt Lake City, UT $12,080 7% · 4 payments
  4. Guy Young Pediatric Hematology-Oncology · Bozeman, MT $11,685 7% · 4 payments
  5. Jenny Gober McDaniel Pediatric Hematology-Oncology · Las Vegas, NV $11,066 7% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Pediatric Hematology-Oncology Pediatrics $148,434 90% · 64 practitioners
  2. Hematology & Oncology Internal Medicine $8,376 5% · 32 practitioners
  3. Hematology Internal Medicine $4,851 3% · 4 practitioners
  4. Pediatrics $819 <1% · 17 practitioners
  5. Medical Oncology Internal Medicine $240 <1% · 10 practitioners

The top 5 of 29 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Connecticut $19,219 12% · 1 recipient
  2. Tennessee $18,890 11% · 15 recipients
  3. California $17,554 11% · 12 recipients
  4. Florida $16,823 10% · 51 recipients
  5. Utah $12,080 7% · 1 recipient

The top 5 of 28 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

Records

348 general · 402 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record